Maximilian LeRoux, who has worked as Nightingale Health Plc's Chief Commercial Officer since August 2023, has left the company as of 27 November 2023. LeRoux's responsibilities will, for the time being, be transferred to other Management Team members of Nightingale Health Plc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.86 EUR | -4.37% | +18.47% | +66.67% |
Apr. 16 | Finland’s Nightingale Health Plots US Expansion | MT |
Apr. 16 | Nightingale Health to Establish A Laboratory in the United States | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+66.67% | 120M | |
+4.36% | 32.47B | |
+14.14% | 7.45B | |
+22.93% | 3.89B | |
-16.29% | 3.15B | |
-25.96% | 1.28B | |
-36.14% | 1.09B | |
-35.42% | 902M | |
-0.13% | 893M | |
-24.12% | 857M |
- Stock Market
- Equities
- HEALTH Stock
- News Nightingale Health Oyj
- Nightingale Health plc Announces Maximilian Leroux Leaves as Chief Commercial Officer